Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder

Converging evidence suggests bioenergetic abnormalities in bipolar disorder (BD). In the brain, phosphocreatine (PCr) acts a reservoir of high-energy phosphate (HEP) bonds, and creatine kinases (CK) catalyze the transfer of HEP from adenosine triphosphate (ATP) to PCr and from PCr back to ATP, at times of increased need. This study examined the activity of this mechanism in BD by measuring the levels of HEP molecules during a stimulus paradigm that increased local energy demand. Twenty-three patients diagnosed with BD-I and 22 healthy controls (HC) were included. Levels of phosphorus metabolites were measured at baseline and during visual stimulation in the occipital lobe using 31P magnetic resonance spectroscopy at 4T. Changes in metabolite levels showed different patterns between the groups. During stimulation, HC had significant reductions in PCr but not in ATP, as expected. In contrast, BD patients had significant reductions in ATP but not in PCr. In addition, PCr/ATP ratio was lower at baseline in patients, and there was a higher change in this measure during stimulation. This pattern suggests a disease-related failure to replenish ATP from PCr through CK enzyme catalysis during tissue activation. Further studies measuring the CK flux in BD are required to confirm and extend this finding.

[1]  William C Clegern,et al.  Sleep slow-wave activity regulates cerebral glycolytic metabolism. , 2013, Cerebral cortex.

[2]  F. Oerlemans,et al.  Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms , 2003, The Journal of physiology.

[3]  T. Inubushi,et al.  Effect of photic stimulation on energy metabolism in the human brain measured by 31P-MR spectroscopy. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[4]  G. Fein,et al.  Abnormal frontal lobe phosphorous metabolism in bipolar disorder. , 1995, The American journal of psychiatry.

[5]  B. Cohen,et al.  In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. , 2014, JAMA psychiatry.

[6]  J. Quevedo,et al.  Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine , 2013, Pharmacology Biochemistry and Behavior.

[7]  G. Kemp,et al.  Non-Invasive Methods for Studying Brain Energy Metabolism: What They Show and What It Means , 2000, Developmental Neuroscience.

[8]  A. Kavushansky,et al.  Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia , 2011, Biological Psychiatry.

[9]  Dost Öngür,et al.  Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders , 2010, Biological Psychiatry.

[10]  G. Fein,et al.  Effect of Photic Stimulation on Human Visual Cortex Lactate and Phosphates Using 1H and 31P Magnetic Resonance Spectroscopy , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  P. Renshaw,et al.  Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy , 2007, Progress in Neuro-psychopharmacology and Biological Psychiatry.

[12]  J. Prince,et al.  Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. , 1997, The Journal of pharmacology and experimental therapeutics.

[13]  J. Quevedo,et al.  Effect of antipsychotics on creatine kinase activity in rat brain. , 2007, Basic & clinical pharmacology & toxicology.

[14]  D. Ongur,et al.  Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. , 2007, Archives of general psychiatry.

[15]  T. Inubushi,et al.  Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. , 1993, Journal of affective disorders.

[16]  J. Prince,et al.  A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics , 1998, European Neuropsychopharmacology.

[17]  H. Manji,et al.  Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. , 2009, The international journal of neuropsychopharmacology.

[18]  T. Inubushi,et al.  Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia , 1995, Psychiatry Research: Neuroimaging.

[19]  J. Quevedo,et al.  Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression , 2008, Neurochemistry International.

[20]  J. Quevedo,et al.  Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  B. Cohen,et al.  Creatine kinase and ATP synthase reaction rates in human frontal lobe measured by ³¹P magnetization transfer spectroscopy at 4T. , 2013, Magnetic resonance imaging.

[22]  P. Renshaw,et al.  Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research , 2005, Molecular Psychiatry.

[23]  F. McMahon,et al.  Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder , 1997, Biological Psychiatry.

[24]  In Kyoon Lyoo,et al.  Brain metabolic alterations in medication-free patients with bipolar disorder. , 2004, Archives of general psychiatry.

[25]  V A Saks,et al.  Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. , 1996, Biochimica et biophysica acta.

[26]  H. Volz,et al.  Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. , 2009, Bipolar disorders.

[27]  Paul C Guest,et al.  Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortex. , 2009, Journal of proteome research.

[28]  J. Quevedo,et al.  Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. , 2010, Journal of psychiatric research.

[29]  J C Mazziotta,et al.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.

[30]  G J Brewer,et al.  Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β‐Amyloid in Rat Hippocampal Neurons , 2000, Journal of neurochemistry.

[31]  D. Ben-shachar,et al.  Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells. , 2009, Biochemical pharmacology.

[32]  C. Konradi,et al.  Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. , 2006, Bipolar disorders.

[33]  T. Inubushi,et al.  Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. , 1994, Journal of affective disorders.

[34]  T. Inubushi,et al.  Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder , 1994, Psychiatry Research: Neuroimaging.

[35]  R. Kauppinen,et al.  31P magnetic resonance spectroscopy study of the human visual cortex during stimulation in mild hypoxic hypoxia , 2008, Experimental Brain Research.

[36]  R G Shulman,et al.  Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy , 1985, Neurology.

[37]  Olivier Braissant,et al.  Synthesis and transport of creatine in the CNS: importance for cerebral functions , 2010, Journal of neurochemistry.

[38]  K Ugurbil,et al.  Increase of creatine kinase activity in the visual cortex of human brain during visual stimulation: A 31p NMR magnetization transfer study , 1997, Magnetic resonance in medicine.

[39]  G. Réus,et al.  Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain , 2009, Brain Research Bulletin.

[40]  R. McCarley,et al.  Sleep and Brain Energy Levels: ATP Changes during Sleep , 2010, The Journal of Neuroscience.

[41]  J. Quevedo,et al.  Brain creatine kinase activity in an animal model of mania. , 2008, Life sciences.

[42]  G. Fein,et al.  Decreased temporal lobe phosphomonoesters in bipolar disorder. , 1995, Journal of affective disorders.

[43]  P. Renshaw,et al.  A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder , 2012, Translational Psychiatry.

[44]  Anne E Carpenter,et al.  Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. , 2010, The American journal of pathology.

[45]  N. Kato,et al.  Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy , 2000, Psychological Medicine.

[46]  N. Kato,et al.  Reduced intracellular pH in the basal ganglia and whole brain measured by 31P‐MRS in bipolar disorder , 2004, Psychiatry and clinical neurosciences.

[47]  N. Kato,et al.  Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[48]  K. Sahlin,et al.  The creatine kinase reaction: a simple reaction with functional complexity , 2011, Amino Acids.

[49]  N. Kato,et al.  Age-dependent alteration of metabolic response to photic stimulation in the human brain measured by 31 P MR-spectroscopy , 1999, Brain Research.

[50]  H. Manji,et al.  Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder , 2008, Neuropsychopharmacology.

[51]  N. Koshoridze,et al.  Social isolation in rats inhibits oxidative metabolism, decreases the content of mitochondrial K-Ras and activates mitochondrial hexokinase , 2009, Behavioural Brain Research.

[52]  Brian A Wandell,et al.  Visual field map clusters in human cortex , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[53]  L. Xin,et al.  Investigating the Metabolic Changes due to Visual Stimulation using Functional Proton Magnetic Resonance Spectroscopy at 7 T , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  K Uğurbil,et al.  31P NMR spectroscopy of the human heart at 4 T: Detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium , 1992, Magnetic resonance in medicine.

[55]  J. Leza,et al.  Glutathione Depletion, Lipid Peroxidation and Mitochondrial Dysfunction Are Induced by Chronic Stress in Rat Brain , 2001, Neuropsychopharmacology.

[56]  G Scarlato,et al.  Energetics of 3.5 s neural activation in humans: A 31P MR spectroscopy study , 1997, Magnetic resonance in medicine.

[57]  G. Repetto,et al.  In vitro effects of lithium and nickel at different levels on Neuro-2a mouse neuroblastoma cells. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[58]  S. Przedborski,et al.  Neuroleptic medications inhibit complex I of the electron transport chain , 1994, Annals of neurology.

[59]  J. Prince,et al.  Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine , 1997, Neuropharmacology.